Insight & Intelligence

More »


More »

For full access to this article login to GEN Select now.

January 01, 2016 (Vol. 36, No. 1)

Integral Molecular Sizes Up Ebola

Membrane Protein Specialist Maps Ebola’s Binding Sites to Advance Vaccine Discovery

  • Ebola is the latest in a series of pathogenic viruses investigated by Integral Molecular, a research-oriented biotechnology company that has a sharp eye for viral membrane proteins. Before Integral Molecular turned its watchful gaze toward Ebola, the company kept tabs on chikungunya, hepatitis C, respiratory syncytial virus, and HIV. ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.